@article{2908a185e1d54cfba34b598d032c3323,
title = "Cutaneous reaction reported after third Moderna COVID-19 vaccine",
keywords = "COVID-19, Moderna, delayed hypersensitivity reaction, general dermatology, mRNA vaccine, medical dermatology, reaction",
author = "Gu{\'e}nin, \{Sophie H.\} and Mindy Kresch and Emily Elbogen and Lebwohl, \{Mark G.\}",
note = "Funding Information: Mark Lebwohl is an employee of Mount Sinai and receives research funds from Abbvie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Dermavant Sciences, Eli Lilly, Incyte, Janssen Research \& Development, LLC, Ortho Dermatologics, Regeneron, and UCB, Inc, and is a consultant for Aditum Bio, Almirall, AltruBio Inc, AnaptysBio, Arcutis, Inc, Aristea Therapeutics, Arrive Technologies, Avotres Therapeutics, BiomX, Boehringer Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Dr Reddy's Laboratories, Evelo Biosciences, Evommune, Inc, Facilitation of International Dermatology Education, Forte Biosciences, Foundation for Research and Education in Dermatology, Helsinn Therapeutics, Hexima Ltd, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Seanergy, and Verrica. Authors Gu{\'e}nin, Kresch, and Elbogen have no conflicts of interest to declare.",
year = "2021",
month = dec,
doi = "10.1016/j.jdcr.2021.10.017",
language = "English",
volume = "18",
pages = "49--50",
journal = "JAAD Case Reports",
issn = "2352-5126",
publisher = "Elsevier Inc.",
}